Skip to content
OpenCapital
Get started

MapLight Therapeutics, Inc. MPLT Cash Flow Statement

Income StatementBalance SheetCash FlowRatiosSegments
QuarterlyAnnualTTM
YoY
SimplifiedDetailed
FY'25
Net income
-$161.15M-108%
Depreciation and amortization
$578K—
Stock-based compensation
——
Net cash from operating activities
——
Capital expenditures
——
Net cash from investing activities
——
Net cash from financing activities
——
Net increase (decrease) in cash
——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does MapLight Therapeutics, Inc. generate?
MapLight Therapeutics, Inc. (MPLT) generated -$145.0M in operating cash flow over the trailing twelve months.
Where does MapLight Therapeutics, Inc. 's cash flow data come from?
Every line is extracted from MapLight Therapeutics, Inc. 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.